vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and MANHATTAN BRIDGE CAPITAL, INC (LOAN). Click either name above to swap in a different company.

MANHATTAN BRIDGE CAPITAL, INC is the larger business by last-quarter revenue ($2.1M vs $1.8M, roughly 1.2× INVO Fertility, Inc.). MANHATTAN BRIDGE CAPITAL, INC runs the higher net margin — 61.6% vs -150.5%, a 212.1% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -9.1%). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -8.0%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Manhattan Bridge Capital, Inc. is a U.S.-based real estate finance firm that provides short-term asset-backed secured loans primarily to real estate investors. Its core offerings include bridge loans for residential and commercial property acquisitions, rehabilitation, and refinancing, serving clients across key U.S. real estate markets.

IVF vs LOAN — Head-to-Head

Bigger by revenue
LOAN
LOAN
1.2× larger
LOAN
$2.1M
$1.8M
IVF
Growing faster (revenue YoY)
IVF
IVF
+31.7% gap
IVF
22.6%
-9.1%
LOAN
Higher net margin
LOAN
LOAN
212.1% more per $
LOAN
61.6%
-150.5%
IVF
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-8.0%
LOAN

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
IVF
IVF
LOAN
LOAN
Revenue
$1.8M
$2.1M
Net Profit
$-2.6M
$1.3M
Gross Margin
Operating Margin
-93.1%
61.4%
Net Margin
-150.5%
61.6%
Revenue YoY
22.6%
-9.1%
Net Profit YoY
-62.2%
-7.2%
EPS (diluted)
$-0.77
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
LOAN
LOAN
Q1 26
$2.1M
Q4 25
$2.0M
Q3 25
$1.8M
$2.0M
Q2 25
$1.9M
$2.4M
Q1 25
$1.6M
$2.3M
Q4 24
$1.7M
$2.4M
Q3 24
$1.4M
$2.3M
Q2 24
$1.8M
$2.4M
Net Profit
IVF
IVF
LOAN
LOAN
Q1 26
$1.3M
Q4 25
$1.1M
Q3 25
$-2.6M
$1.2M
Q2 25
$-5.3M
$1.4M
Q1 25
$-17.4M
$1.4M
Q4 24
$-3.6M
$1.3M
Q3 24
$-1.6M
$1.4M
Q2 24
$-2.2M
$1.4M
Gross Margin
IVF
IVF
LOAN
LOAN
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Operating Margin
IVF
IVF
LOAN
LOAN
Q1 26
61.4%
Q4 25
55.9%
Q3 25
-93.1%
58.8%
Q2 25
-160.4%
59.9%
Q1 25
-1042.1%
60.2%
Q4 24
-202.0%
55.2%
Q3 24
-90.7%
60.3%
Q2 24
-100.9%
57.5%
Net Margin
IVF
IVF
LOAN
LOAN
Q1 26
61.6%
Q4 25
56.1%
Q3 25
-150.5%
59.1%
Q2 25
-283.6%
60.0%
Q1 25
-1060.1%
60.4%
Q4 24
-211.3%
55.4%
Q3 24
-113.8%
60.5%
Q2 24
-122.2%
57.7%
EPS (diluted)
IVF
IVF
LOAN
LOAN
Q1 26
$0.11
Q4 25
$0.10
Q3 25
$-0.77
$0.11
Q2 25
$-13.30
$0.12
Q1 25
$-12.53
$0.12
Q4 24
$14.86
$0.12
Q3 24
$-15.11
$0.12
Q2 24
$-22.39
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
LOAN
LOAN
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$43.1M
Total Assets
$18.8M
$64.3M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Total Debt
IVF
IVF
LOAN
LOAN
Q1 26
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Stockholders' Equity
IVF
IVF
LOAN
LOAN
Q1 26
$43.1M
Q4 25
$43.1M
Q3 25
$5.8M
$43.3M
Q2 25
$2.6M
$43.4M
Q1 25
$3.3M
$43.3M
Q4 24
$12.7M
$43.3M
Q3 24
$-23.3K
$43.3M
Q2 24
$1.4M
$43.2M
Total Assets
IVF
IVF
LOAN
LOAN
Q1 26
$64.3M
Q4 25
$62.4M
Q3 25
$18.8M
$60.0M
Q2 25
$19.3M
$67.6M
Q1 25
$31.7M
$65.8M
Q4 24
$46.4M
$67.4M
Q3 24
$17.0M
$70.7M
Q2 24
$17.8M
$68.8M
Debt / Equity
IVF
IVF
LOAN
LOAN
Q1 26
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
LOAN
LOAN
Operating Cash FlowLast quarter
$-1.8M
$1.3M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
LOAN
LOAN
Q1 26
$1.3M
Q4 25
$4.9M
Q3 25
$-1.8M
$1.4M
Q2 25
$-1.7M
$1.2M
Q1 25
$-3.5M
$1.2M
Q4 24
$-617.4K
$4.9M
Q3 24
$-640.8K
$1.2M
Q2 24
$-1.5M
$1.3M
Free Cash Flow
IVF
IVF
LOAN
LOAN
Q1 26
Q4 25
$4.9M
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
$4.9M
Q3 24
$1.2M
Q2 24
$-1.5M
FCF Margin
IVF
IVF
LOAN
LOAN
Q1 26
Q4 25
246.2%
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
208.9%
Q3 24
53.3%
Q2 24
-82.3%
Capex Intensity
IVF
IVF
LOAN
LOAN
Q1 26
Q4 25
0.0%
Q3 25
0.5%
0.0%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
0.2%
Q3 24
0.0%
0.1%
Q2 24
3.0%
Cash Conversion
IVF
IVF
LOAN
LOAN
Q1 26
0.99×
Q4 25
4.39×
Q3 25
1.16×
Q2 25
0.87×
Q1 25
0.86×
Q4 24
3.78×
Q3 24
0.88×
Q2 24
0.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons